# Nextdoor timeline entity: /record/nextdoor.md id: ent_nextdoor ## undated - undated | state_of_incorporation | DE | valid | [clm_000444FB5C08](/claim/clm_000444FB5C08.md) - undated | ticker | NXDR | valid | [clm_05BC323728FD](/claim/clm_05BC323728FD.md) - undated to 2021-02-12 | registrant_name | Nextdoor Holdings, Inc. | superseded | [clm_4E9D45D96AD2](/claim/clm_4E9D45D96AD2.md) - undated | listed_on | Nasdaq | valid | [clm_686F7A2107B5](/claim/clm_686F7A2107B5.md) - undated | fiscal_year_end | 12-31 | valid | [clm_746963D7473C](/claim/clm_746963D7473C.md) - undated | cik | 0001846069 | valid | [clm_AC9688D1587D](/claim/clm_AC9688D1587D.md) - undated | sic_industry | Services-Computer Programming, Data Processing, Etc. (7370) | valid | [clm_D624D46BFD6E](/claim/clm_D624D46BFD6E.md) - undated | website | https://nextdoor.com/ | unverified | [clm_E781E03FCA91](/claim/clm_E781E03FCA91.md) ## 2011 - 2011-06-22 | x_username | Nextdoor | unverified | [clm_5A14929A09C5](/claim/clm_5A14929A09C5.md) ## 2018 - 2018-10-01 to 2024-05-08 | ceo | Sarah Friar | superseded | [clm_E624032AEFAA](/claim/clm_E624032AEFAA.md) ## 2019 - 2019-12-31 to 2020-12-31 | total_equity | -257,296,000 United States dollar | superseded | [clm_581A89BA6401](/claim/clm_581A89BA6401.md) ## 2020 - 2020-12-31 to 2021-03-31 | total_assets | 217,747,000 United States dollar | superseded | [clm_1C88025A74A5](/claim/clm_1C88025A74A5.md) - 2020-12-31 to 2021-03-31 | cash_and_equivalents | 83,642,000 United States dollar | superseded | [clm_1E7C8E60799A](/claim/clm_1E7C8E60799A.md) - 2020-12-31 to 2021-12-31 | operating_income | -76,651,000 United States dollar | superseded | [clm_658E1EEA5901](/claim/clm_658E1EEA5901.md) - 2020-12-31 to 2021-03-31 | total_equity | -297,856,000 United States dollar | superseded | [clm_6F031DFF34B2](/claim/clm_6F031DFF34B2.md) - 2020-12-31 to 2021-12-31 | research_and_development | 69,231,000 United States dollar | superseded | [clm_89C8FEAF33DB](/claim/clm_89C8FEAF33DB.md) - 2020-12-31 to 2021-12-31 | net_income | -75,234,000 United States dollar | superseded | [clm_F91D3B1D33EC](/claim/clm_F91D3B1D33EC.md) - 2020-12-31 to 2021-12-31 | revenue | 123,284,000 United States dollar | superseded | [clm_FABA6B9C9164](/claim/clm_FABA6B9C9164.md) ## 2021 - 2021-02-12 to 2021-11-03 | registrant_name | Khosla Ventures Acquisition Co. II | superseded | [clm_ECA5A34FBB0B](/claim/clm_ECA5A34FBB0B.md) - 2021-03-31 to 2021-06-30 | quarterly_research_and_development | 20,820,000 United States dollar | superseded | [clm_14F83F5B92B3](/claim/clm_14F83F5B92B3.md) - 2021-03-31 to 2021-06-30 | total_assets | 419,322,007 United States dollar | superseded | [clm_18AD3AAEA8EF](/claim/clm_18AD3AAEA8EF.md) - 2021-03-31 to 2021-06-30 | quarterly_revenue | 34,387,000 United States dollar | superseded | [clm_7D17BB8F2866](/claim/clm_7D17BB8F2866.md) - 2021-03-31 to 2021-06-30 | cash_and_equivalents | 1,685,423 United States dollar | superseded | [clm_CD997C9E5106](/claim/clm_CD997C9E5106.md) - 2021-03-31 to 2021-06-30 | total_equity | 5,000,010 United States dollar | superseded | [clm_D1BB644C47A3](/claim/clm_D1BB644C47A3.md) - 2021-03-31 to 2021-06-30 | quarterly_net_income | -25,140,000 United States dollar | superseded | [clm_D8DB0DEB0BF2](/claim/clm_D8DB0DEB0BF2.md) - 2021-03-31 to 2021-06-30 | quarterly_operating_income | -24,993,000 United States dollar | superseded | [clm_EF548EACD573](/claim/clm_EF548EACD573.md) - 2021-06-30 to 2021-09-30 | cash_and_equivalents | 978,280 United States dollar | superseded | [clm_3DDBAE14AA48](/claim/clm_3DDBAE14AA48.md) - 2021-06-30 to 2021-09-30 | total_equity | -29,177,744 United States dollar | superseded | [clm_8150AB32B2C3](/claim/clm_8150AB32B2C3.md) - 2021-06-30 to 2021-09-30 | quarterly_revenue | 45,778,000 United States dollar | superseded | [clm_8F81667FF1B9](/claim/clm_8F81667FF1B9.md) - 2021-06-30 to 2021-09-30 | quarterly_research_and_development | 23,331,000 United States dollar | superseded | [clm_B7E48572B040](/claim/clm_B7E48572B040.md) - 2021-06-30 to 2021-09-30 | quarterly_net_income | -3,261,529 United States dollar | superseded | [clm_C162E3EAEAE1](/claim/clm_C162E3EAEAE1.md) - 2021-06-30 to 2021-09-30 | quarterly_operating_income | -317,856 United States dollar | superseded | [clm_C8DD606B33FE](/claim/clm_C8DD606B33FE.md) - 2021-06-30 to 2021-09-30 | total_assets | 418,458,289 United States dollar | superseded | [clm_E611D30E53C1](/claim/clm_E611D30E53C1.md) - 2021-09-30 to 2021-12-31 | cash_and_equivalents | 572,360 United States dollar | superseded | [clm_1BC1710DD23D](/claim/clm_1BC1710DD23D.md) - 2021-09-30 to 2022-03-31 | quarterly_research_and_development | 25,461,000 United States dollar | superseded | [clm_6DFF7379F247](/claim/clm_6DFF7379F247.md) - 2021-09-30 to 2022-03-31 | quarterly_revenue | 52,705,000 United States dollar | superseded | [clm_9FF692206E0A](/claim/clm_9FF692206E0A.md) - 2021-09-30 to 2022-03-31 | quarterly_operating_income | -2,245,939 United States dollar | superseded | [clm_A0467F8992DD](/claim/clm_A0467F8992DD.md) - 2021-09-30 to 2022-03-31 | quarterly_net_income | 4,008,374 United States dollar | superseded | [clm_BB8939F43E81](/claim/clm_BB8939F43E81.md) - 2021-09-30 to 2021-12-31 | total_equity | -25,180,010 United States dollar | superseded | [clm_D046451E4CAB](/claim/clm_D046451E4CAB.md) - 2021-09-30 to 2021-12-31 | total_assets | 417,891,992 United States dollar | superseded | [clm_EEACB5446BD7](/claim/clm_EEACB5446BD7.md) - 2021-12-31 to 2022-03-31 | cash_and_equivalents | 521,812,000 United States dollar | superseded | [clm_06D76BBB842D](/claim/clm_06D76BBB842D.md) - 2021-12-31 to 2022-12-31 | revenue | 192,197,000 United States dollar | superseded | [clm_27BD89DCC17B](/claim/clm_27BD89DCC17B.md) - 2021-12-31 to 2022-03-31 | total_equity | 744,985,000 United States dollar | superseded | [clm_36583B79E36A](/claim/clm_36583B79E36A.md) - 2021-12-31 to 2022-12-31 | net_income | -95,325,000 United States dollar | superseded | [clm_4AC5E1B6D6BD](/claim/clm_4AC5E1B6D6BD.md) - 2021-12-31 to 2022-12-31 | operating_income | -94,806,000 United States dollar | superseded | [clm_7880FBF29F35](/claim/clm_7880FBF29F35.md) - 2021-12-31 to 2022-03-31 | total_assets | 840,086,000 United States dollar | superseded | [clm_D452F5987A36](/claim/clm_D452F5987A36.md) - 2021-12-31 to 2022-12-31 | research_and_development | 97,096,000 United States dollar | superseded | [clm_EDA67744ACB6](/claim/clm_EDA67744ACB6.md) ## 2022 - 2022-03-31 to 2022-06-30 | quarterly_research_and_development | 28,960,000 United States dollar | superseded | [clm_362EE2521B9B](/claim/clm_362EE2521B9B.md) - 2022-03-31 to 2022-06-30 | total_assets | 822,199,000 United States dollar | superseded | [clm_445CE6F92876](/claim/clm_445CE6F92876.md) - 2022-03-31 to 2022-06-30 | quarterly_net_income | -32,948,000 United States dollar | superseded | [clm_807801823068](/claim/clm_807801823068.md) - 2022-03-31 to 2022-06-30 | quarterly_operating_income | -33,226,000 United States dollar | superseded | [clm_AE0611C39DA4](/claim/clm_AE0611C39DA4.md) - 2022-03-31 to 2022-06-30 | cash_and_equivalents | 207,968,000 United States dollar | superseded | [clm_BE2758405318](/claim/clm_BE2758405318.md) - 2022-03-31 to 2022-06-30 | quarterly_revenue | 51,000,000 United States dollar | superseded | [clm_EFF74EDA99DB](/claim/clm_EFF74EDA99DB.md) - 2022-03-31 to 2022-06-30 | total_equity | 727,666,000 United States dollar | superseded | [clm_F48BE0612528](/claim/clm_F48BE0612528.md) - 2022-06-30 to 2022-09-30 | cash_and_equivalents | 40,186,000 United States dollar | superseded | [clm_3477EDC060B2](/claim/clm_3477EDC060B2.md) - 2022-06-30 to 2022-09-30 | quarterly_net_income | -36,843,000 United States dollar | superseded | [clm_3BC2B8853B11](/claim/clm_3BC2B8853B11.md) - 2022-06-30 to 2022-09-30 | quarterly_operating_income | -38,255,000 United States dollar | superseded | [clm_42E48DBF4CE5](/claim/clm_42E48DBF4CE5.md) - 2022-06-30 to 2022-09-30 | quarterly_revenue | 54,541,000 United States dollar | superseded | [clm_66E96A217FB0](/claim/clm_66E96A217FB0.md) - 2022-06-30 to 2022-09-30 | total_assets | 793,164,000 United States dollar | superseded | [clm_9101BEF325CA](/claim/clm_9101BEF325CA.md) - 2022-06-30 to 2022-09-30 | quarterly_research_and_development | 32,699,000 United States dollar | superseded | [clm_B2B01C808B49](/claim/clm_B2B01C808B49.md) - 2022-06-30 to 2022-09-30 | total_equity | 701,458,000 United States dollar | superseded | [clm_CDB20A9CDD69](/claim/clm_CDB20A9CDD69.md) - 2022-09-30 to 2022-12-31 | total_equity | 623,454,000 United States dollar | superseded | [clm_0D99B0CF38EC](/claim/clm_0D99B0CF38EC.md) - 2022-09-30 to 2022-12-31 | cash_and_equivalents | 90,731,000 United States dollar | superseded | [clm_17A6C0F3C77B](/claim/clm_17A6C0F3C77B.md) - 2022-09-30 to 2023-03-31 | quarterly_research_and_development | 33,398,000 United States dollar | superseded | [clm_26157CC71ED1](/claim/clm_26157CC71ED1.md) - 2022-09-30 to 2023-03-31 | quarterly_operating_income | -36,392,000 United States dollar | superseded | [clm_35A5D5B19D32](/claim/clm_35A5D5B19D32.md) - 2022-09-30 to 2022-12-31 | total_assets | 713,929,000 United States dollar | superseded | [clm_540FFEF9B646](/claim/clm_540FFEF9B646.md) - 2022-09-30 to 2023-03-31 | quarterly_revenue | 53,954,000 United States dollar | superseded | [clm_8E205FABA5E0](/claim/clm_8E205FABA5E0.md) - 2022-09-30 to 2023-03-31 | quarterly_net_income | -34,717,000 United States dollar | superseded | [clm_C4FC70441A02](/claim/clm_C4FC70441A02.md) - 2022-12-31 to 2025-12-31 | employees | 704 | superseded | [clm_029F787BE309](/claim/clm_029F787BE309.md) - 2022-12-31 to 2023-12-31 | operating_income | -144,204,000 United States dollar | superseded | [clm_1122A4709B3C](/claim/clm_1122A4709B3C.md) - 2022-12-31 to 2023-12-31 | net_income | -137,916,000 United States dollar | superseded | [clm_5412085A7092](/claim/clm_5412085A7092.md) - 2022-12-31 to 2023-12-31 | revenue | 212,765,000 United States dollar | superseded | [clm_8D74B0344887](/claim/clm_8D74B0344887.md) - 2022-12-31 to 2023-03-31 | total_equity | 611,068,000 United States dollar | superseded | [clm_A76AD38AA568](/claim/clm_A76AD38AA568.md) - 2022-12-31 to 2023-12-31 | research_and_development | 127,073,000 United States dollar | superseded | [clm_AD47A8B83904](/claim/clm_AD47A8B83904.md) - 2022-12-31 to 2023-03-31 | cash_and_equivalents | 55,236,000 United States dollar | superseded | [clm_B92E54F0506B](/claim/clm_B92E54F0506B.md) - 2022-12-31 to 2023-03-31 | total_assets | 699,562,000 United States dollar | superseded | [clm_E5C0EB2889F1](/claim/clm_E5C0EB2889F1.md) ## 2023 - 2023-03-31 to 2023-06-30 | quarterly_research_and_development | 32,982,000 United States dollar | superseded | [clm_13F8941D51DD](/claim/clm_13F8941D51DD.md) - 2023-03-31 to 2023-06-30 | cash_and_equivalents | 67,818,000 United States dollar | superseded | [clm_6B45C0F226BF](/claim/clm_6B45C0F226BF.md) - 2023-03-31 to 2023-06-30 | quarterly_net_income | -33,716,000 United States dollar | superseded | [clm_8A9AD8DF3061](/claim/clm_8A9AD8DF3061.md) - 2023-03-31 to 2023-06-30 | total_assets | 694,786,000 United States dollar | superseded | [clm_975746AF5423](/claim/clm_975746AF5423.md) - 2023-03-31 to 2023-06-30 | quarterly_revenue | 49,771,000 United States dollar | superseded | [clm_D66F3571687B](/claim/clm_D66F3571687B.md) - 2023-03-31 to 2023-06-30 | quarterly_operating_income | -38,812,000 United States dollar | superseded | [clm_EA10A541D82B](/claim/clm_EA10A541D82B.md) - 2023-03-31 to 2023-06-30 | total_equity | 596,424,000 United States dollar | superseded | [clm_F0491A37F9B8](/claim/clm_F0491A37F9B8.md) - 2023-06-30 to 2023-09-30 | quarterly_research_and_development | 37,117,000 United States dollar | superseded | [clm_236BB7FD0B05](/claim/clm_236BB7FD0B05.md) - 2023-06-30 to 2023-09-30 | total_assets | 684,037,000 United States dollar | superseded | [clm_4019D8E8353D](/claim/clm_4019D8E8353D.md) - 2023-06-30 to 2023-09-30 | total_equity | 583,078,000 United States dollar | superseded | [clm_6657E122E8CB](/claim/clm_6657E122E8CB.md) - 2023-06-30 to 2023-09-30 | quarterly_revenue | 56,889,000 United States dollar | superseded | [clm_69F98D8B2715](/claim/clm_69F98D8B2715.md) - 2023-06-30 to 2023-09-30 | quarterly_operating_income | -41,442,000 United States dollar | superseded | [clm_B60CAD53381F](/claim/clm_B60CAD53381F.md) - 2023-06-30 to 2023-09-30 | cash_and_equivalents | 74,268,000 United States dollar | superseded | [clm_DA8E22FF9AA3](/claim/clm_DA8E22FF9AA3.md) - 2023-06-30 to 2023-09-30 | quarterly_net_income | -35,403,000 United States dollar | superseded | [clm_E204108A415F](/claim/clm_E204108A415F.md) - 2023-09-30 to 2023-12-31 | cash_and_equivalents | 48,444,000 United States dollar | superseded | [clm_001F75D167D7](/claim/clm_001F75D167D7.md) - 2023-09-30 to 2024-03-31 | quarterly_operating_income | -44,376,000 United States dollar | superseded | [clm_0AB2C238FCB3](/claim/clm_0AB2C238FCB3.md) - 2023-09-30 to 2024-03-31 | quarterly_revenue | 56,092,000 United States dollar | superseded | [clm_0F795E4C7028](/claim/clm_0F795E4C7028.md) - 2023-09-30 to 2023-12-31 | total_assets | 670,100,000 United States dollar | superseded | [clm_510F241F133D](/claim/clm_510F241F133D.md) - 2023-09-30 to 2023-12-31 | total_equity | 573,181,000 United States dollar | superseded | [clm_C151EEC32E89](/claim/clm_C151EEC32E89.md) - 2023-09-30 to 2024-03-31 | quarterly_research_and_development | 39,649,000 United States dollar | superseded | [clm_D153659D4DCD](/claim/clm_D153659D4DCD.md) - 2023-09-30 to 2024-03-31 | quarterly_net_income | -38,116,000 United States dollar | superseded | [clm_DA9A029B0C38](/claim/clm_DA9A029B0C38.md) - 2023-10-17 | board_member | Dana Evan | valid | [clm_4FB0CAC16679](/claim/clm_4FB0CAC16679.md) - 2023-11-07 | cfo | Matt Anderson | valid | [clm_F50312E88778](/claim/clm_F50312E88778.md) - 2023-12-31 to 2024-12-31 | net_income | -147,765,000 United States dollar | superseded | [clm_200559133A17](/claim/clm_200559133A17.md) - 2023-12-31 to 2024-12-31 | revenue | 218,309,000 United States dollar | superseded | [clm_603168ACEBA5](/claim/clm_603168ACEBA5.md) - 2023-12-31 to 2024-03-31 | total_assets | 654,564,000 United States dollar | superseded | [clm_85A2DB1EA32B](/claim/clm_85A2DB1EA32B.md) - 2023-12-31 to 2024-03-31 | cash_and_equivalents | 60,233,000 United States dollar | superseded | [clm_9F8B7A426E1F](/claim/clm_9F8B7A426E1F.md) - 2023-12-31 to 2024-12-31 | operating_income | -172,284,000 United States dollar | superseded | [clm_CB00EED0C0C9](/claim/clm_CB00EED0C0C9.md) - 2023-12-31 to 2024-03-31 | total_equity | 558,557,000 United States dollar | superseded | [clm_DDF2D43C0600](/claim/clm_DDF2D43C0600.md) - 2023-12-31 to 2024-12-31 | research_and_development | 149,998,000 United States dollar | superseded | [clm_EF2907B5AF9E](/claim/clm_EF2907B5AF9E.md) ## 2024 - 2024-03-31 to 2024-06-30 | cash_and_equivalents | 69,670,000 United States dollar | superseded | [clm_309583626208](/claim/clm_309583626208.md) - 2024-03-31 to 2024-06-30 | quarterly_research_and_development | 31,319,000 United States dollar | superseded | [clm_3E006D5D17FB](/claim/clm_3E006D5D17FB.md) - 2024-03-31 to 2024-06-30 | total_equity | 541,442,000 United States dollar | superseded | [clm_3FED133E8105](/claim/clm_3FED133E8105.md) - 2024-03-31 to 2024-06-30 | total_assets | 633,081,000 United States dollar | superseded | [clm_6686E198F9F7](/claim/clm_6686E198F9F7.md) - 2024-03-31 to 2024-06-30 | quarterly_net_income | -28,261,000 United States dollar | superseded | [clm_7DCE3065F98A](/claim/clm_7DCE3065F98A.md) - 2024-03-31 to 2024-06-30 | quarterly_operating_income | -34,749,000 United States dollar | superseded | [clm_CBD616A5B2C0](/claim/clm_CBD616A5B2C0.md) - 2024-03-31 to 2024-06-30 | quarterly_revenue | 53,146,000 United States dollar | superseded | [clm_E589D9D8D957](/claim/clm_E589D9D8D957.md) - 2024-05-01 | board_member | Niraj Shah | valid | [clm_11541EF4A088](/claim/clm_11541EF4A088.md) - 2024-05-01 | board_member | Marissa Mayer | valid | [clm_8A3EC36E5A97](/claim/clm_8A3EC36E5A97.md) - 2024-05-01 | board_member | Robert Hohman | valid | [clm_E938E2D0D34B](/claim/clm_E938E2D0D34B.md) - 2024-05-08 | chair | Nirav Tolia | valid | [clm_97C84F050661](/claim/clm_97C84F050661.md) - 2024-05-08 | president | Nirav Tolia | valid | [clm_A08D8B0E7D45](/claim/clm_A08D8B0E7D45.md) - 2024-05-08 | ceo | Nirav Tolia | valid | [clm_E659301A78F5](/claim/clm_E659301A78F5.md) - 2024-06-30 to 2024-09-30 | quarterly_research_and_development | 31,102,000 United States dollar | superseded | [clm_4B39903AF4AD](/claim/clm_4B39903AF4AD.md) - 2024-06-30 to 2024-09-30 | total_equity | 472,314,000 United States dollar | superseded | [clm_8C11D3DB4727](/claim/clm_8C11D3DB4727.md) - 2024-06-30 to 2024-09-30 | quarterly_revenue | 63,292,000 United States dollar | superseded | [clm_8DC2D49C76FD](/claim/clm_8DC2D49C76FD.md) - 2024-06-30 to 2024-09-30 | quarterly_net_income | -42,781,000 United States dollar | superseded | [clm_911E07DAAD0F](/claim/clm_911E07DAAD0F.md) - 2024-06-30 to 2024-09-30 | total_assets | 542,069,000 United States dollar | superseded | [clm_A6C15EF25C6F](/claim/clm_A6C15EF25C6F.md) - 2024-06-30 to 2024-09-30 | cash_and_equivalents | 52,960,000 United States dollar | superseded | [clm_A7A5ED0AB0F2](/claim/clm_A7A5ED0AB0F2.md) - 2024-06-30 to 2024-09-30 | quarterly_operating_income | -49,016,000 United States dollar | superseded | [clm_F8812A2FD12B](/claim/clm_F8812A2FD12B.md) - 2024-07-03 | board_member | Elisa Steele | valid | [clm_332E72CC199F](/claim/clm_332E72CC199F.md) - 2024-09-30 to 2024-12-31 | total_assets | 517,663,000 United States dollar | superseded | [clm_466714F22319](/claim/clm_466714F22319.md) - 2024-09-30 to 2024-12-31 | total_equity | 456,045,000 United States dollar | superseded | [clm_65FE4FFD7BF7](/claim/clm_65FE4FFD7BF7.md) - 2024-09-30 to 2025-03-31 | quarterly_net_income | -14,898,000 United States dollar | superseded | [clm_8C6DA71A5F4A](/claim/clm_8C6DA71A5F4A.md) - 2024-09-30 to 2025-03-31 | quarterly_research_and_development | 31,897,000 United States dollar | superseded | [clm_AD13ED90B8E7](/claim/clm_AD13ED90B8E7.md) - 2024-09-30 to 2025-03-31 | quarterly_revenue | 65,610,000 United States dollar | superseded | [clm_AFD6F519F859](/claim/clm_AFD6F519F859.md) - 2024-09-30 to 2025-03-31 | quarterly_operating_income | -20,777,000 United States dollar | superseded | [clm_B46D8AAE26D8](/claim/clm_B46D8AAE26D8.md) - 2024-09-30 to 2024-12-31 | cash_and_equivalents | 49,700,000 United States dollar | superseded | [clm_DD604F5EBA53](/claim/clm_DD604F5EBA53.md) - 2024-12-31 to 2025-12-31 | research_and_development | 127,939,000 United States dollar | superseded | [clm_3F06C2C825B7](/claim/clm_3F06C2C825B7.md) - 2024-12-31 to 2025-12-31 | revenue | 247,276,000 United States dollar | superseded | [clm_408D5F2DAD25](/claim/clm_408D5F2DAD25.md) - 2024-12-31 to 2025-03-31 | total_equity | 453,488,000 United States dollar | superseded | [clm_79AB8A493FE1](/claim/clm_79AB8A493FE1.md) - 2024-12-31 to 2025-12-31 | operating_income | -121,639,000 United States dollar | superseded | [clm_9E2A9FC300E4](/claim/clm_9E2A9FC300E4.md) - 2024-12-31 to 2025-03-31 | total_assets | 513,953,000 United States dollar | superseded | [clm_BBC053137684](/claim/clm_BBC053137684.md) - 2024-12-31 to 2025-03-31 | cash_and_equivalents | 45,550,000 United States dollar | superseded | [clm_BF6F42F8AD44](/claim/clm_BF6F42F8AD44.md) - 2024-12-31 to 2025-12-31 | net_income | -98,063,000 United States dollar | superseded | [clm_C44E53A7CC3F](/claim/clm_C44E53A7CC3F.md) ## 2025 - 2025-03-31 to 2025-06-30 | quarterly_net_income | -21,952,000 United States dollar | superseded | [clm_35EF27D124AB](/claim/clm_35EF27D124AB.md) - 2025-03-31 to 2025-06-30 | total_equity | 436,069,000 United States dollar | superseded | [clm_3AB8A1782B7A](/claim/clm_3AB8A1782B7A.md) - 2025-03-31 to 2025-06-30 | cash_and_equivalents | 57,338,000 United States dollar | superseded | [clm_802D3A03A715](/claim/clm_802D3A03A715.md) - 2025-03-31 to 2025-06-30 | quarterly_operating_income | -27,013,000 United States dollar | superseded | [clm_9AFEE4DBEEF8](/claim/clm_9AFEE4DBEEF8.md) - 2025-03-31 to 2025-06-30 | quarterly_revenue | 54,176,000 United States dollar | superseded | [clm_E3C0BD7E864A](/claim/clm_E3C0BD7E864A.md) - 2025-03-31 to 2025-06-30 | quarterly_research_and_development | 33,494,000 United States dollar | superseded | [clm_E938C43E23C2](/claim/clm_E938C43E23C2.md) - 2025-03-31 to 2025-06-30 | total_assets | 494,962,000 United States dollar | superseded | [clm_F5218C091B89](/claim/clm_F5218C091B89.md) - 2025-06-30 to 2025-09-30 | quarterly_research_and_development | 34,622,000 United States dollar | superseded | [clm_086DB94B3AB5](/claim/clm_086DB94B3AB5.md) - 2025-06-30 to 2025-09-30 | quarterly_net_income | -15,362,000 United States dollar | superseded | [clm_23CE7559231C](/claim/clm_23CE7559231C.md) - 2025-06-30 to 2025-09-30 | quarterly_revenue | 65,093,000 United States dollar | superseded | [clm_63EC7D08957D](/claim/clm_63EC7D08957D.md) - 2025-06-30 to 2025-09-30 | total_assets | 490,355,000 United States dollar | superseded | [clm_718638213CD5](/claim/clm_718638213CD5.md) - 2025-06-30 to 2025-09-30 | quarterly_operating_income | -20,276,000 United States dollar | superseded | [clm_75AD6EBAFDF7](/claim/clm_75AD6EBAFDF7.md) - 2025-06-30 to 2025-09-30 | cash_and_equivalents | 62,050,000 United States dollar | superseded | [clm_88A9400D6818](/claim/clm_88A9400D6818.md) - 2025-06-30 to 2025-09-30 | total_equity | 429,533,000 United States dollar | superseded | [clm_AA3F3A6ADDCD](/claim/clm_AA3F3A6ADDCD.md) - 2025-08-07 | restructuring | Cost reduction plan to accelerate focus and efficiency, with about $5M charges | valid | [clm_DFE8BB7E94A1](/claim/clm_DFE8BB7E94A1.md) - 2025-09-01 | cfo | Nirav Tolia | valid | [clm_44D1D4A13C25](/claim/clm_44D1D4A13C25.md) - 2025-09-30 to 2026-03-31 | quarterly_operating_income | -17,229,000 United States dollar | superseded | [clm_1DBEC752D094](/claim/clm_1DBEC752D094.md) - 2025-09-30 to 2025-12-31 | total_assets | 488,949,000 United States dollar | superseded | [clm_4784366CA339](/claim/clm_4784366CA339.md) - 2025-09-30 to 2026-03-31 | quarterly_research_and_development | 35,674,000 United States dollar | superseded | [clm_4F3648D12AD4](/claim/clm_4F3648D12AD4.md) - 2025-09-30 to 2026-03-31 | quarterly_net_income | -12,857,000 United States dollar | superseded | [clm_8E038EC30C7F](/claim/clm_8E038EC30C7F.md) - 2025-09-30 to 2025-12-31 | total_equity | 429,685,000 United States dollar | superseded | [clm_9189206EA5B9](/claim/clm_9189206EA5B9.md) - 2025-09-30 to 2026-03-31 | quarterly_revenue | 68,898,000 United States dollar | superseded | [clm_ACEB3BD35477](/claim/clm_ACEB3BD35477.md) - 2025-09-30 to 2025-12-31 | cash_and_equivalents | 56,088,000 United States dollar | superseded | [clm_FE1FEBF59DBD](/claim/clm_FE1FEBF59DBD.md) - 2025-12-01 | cfo | Indrajit Ponnambalam | valid | [clm_28EB48F084F5](/claim/clm_28EB48F084F5.md) - 2025-12-31 | operating_income | -71,942,000 United States dollar | valid | [clm_03C40FDC6AA5](/claim/clm_03C40FDC6AA5.md) - 2025-12-31 | employees | 463 | valid | [clm_48D8A70646D6](/claim/clm_48D8A70646D6.md) - 2025-12-31 | net_income | -54,204,000 United States dollar | valid | [clm_4C85A40B1186](/claim/clm_4C85A40B1186.md) - 2025-12-31 to 2026-03-31 | total_equity | 431,283,000 United States dollar | superseded | [clm_65D3300698FF](/claim/clm_65D3300698FF.md) - 2025-12-31 to 2026-03-31 | total_assets | 486,803,000 United States dollar | superseded | [clm_8A51E9413CF2](/claim/clm_8A51E9413CF2.md) - 2025-12-31 | research_and_development | 135,205,000 United States dollar | valid | [clm_95FF2AF2215F](/claim/clm_95FF2AF2215F.md) - 2025-12-31 to 2026-03-31 | cash_and_equivalents | 63,341,000 United States dollar | superseded | [clm_C4F872D2654A](/claim/clm_C4F872D2654A.md) - 2025-12-31 | revenue | 257,646,000 United States dollar | valid | [clm_C713A03ED4FA](/claim/clm_C713A03ED4FA.md) ## 2026 - 2026-03-31 to 2026-06-30 | quarterly_research_and_development | 32,016,000 United States dollar | superseded | [clm_2C5F15100B3C](/claim/clm_2C5F15100B3C.md) - 2026-03-31 to 2026-06-30 | quarterly_operating_income | -15,330,000 United States dollar | superseded | [clm_37D0C52E5027](/claim/clm_37D0C52E5027.md) - 2026-03-31 to 2026-06-30 | total_equity | 401,481,000 United States dollar | superseded | [clm_469269378A6F](/claim/clm_469269378A6F.md) - 2026-03-31 to 2026-06-30 | total_assets | 452,516,000 United States dollar | superseded | [clm_579A2068BC69](/claim/clm_579A2068BC69.md) - 2026-03-31 to 2026-06-30 | quarterly_revenue | 61,669,000 United States dollar | superseded | [clm_CF1ADC920C0D](/claim/clm_CF1ADC920C0D.md) - 2026-03-31 to 2026-06-30 | cash_and_equivalents | 56,148,000 United States dollar | superseded | [clm_D4CA248A52DF](/claim/clm_D4CA248A52DF.md) - 2026-03-31 to 2026-06-30 | quarterly_net_income | -11,417,000 United States dollar | superseded | [clm_E083D1455D54](/claim/clm_E083D1455D54.md) - 2026-06-30 | total_assets | 461,864,000 United States dollar | valid | [clm_36F56CDCE4C5](/claim/clm_36F56CDCE4C5.md) - 2026-06-30 | quarterly_revenue | 74,554,000 United States dollar | valid | [clm_4CC87A1AB1C0](/claim/clm_4CC87A1AB1C0.md) - 2026-06-30 | quarterly_net_income | -2,122,000 United States dollar | valid | [clm_7FD2806A5FF9](/claim/clm_7FD2806A5FF9.md) - 2026-06-30 | cash_and_equivalents | 63,551,000 United States dollar | valid | [clm_BE48E43FB350](/claim/clm_BE48E43FB350.md) - 2026-06-30 | quarterly_operating_income | -5,666,000 United States dollar | valid | [clm_E8135654E62D](/claim/clm_E8135654E62D.md) - 2026-06-30 | total_equity | 410,626,000 United States dollar | valid | [clm_EE59DD280528](/claim/clm_EE59DD280528.md) - 2026-06-30 | quarterly_research_and_development | 32,985,000 United States dollar | valid | [clm_F2613D5A7A4D](/claim/clm_F2613D5A7A4D.md) - 2026-10-01 | delisting_notice | New York Stock Exchange | valid | [clm_797BD3F4D4C5](/claim/clm_797BD3F4D4C5.md) --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.